ProPhase Labs, Inc. Amortization
ProPhase Labs, Inc. (PRPH) reported Amortization of $436.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2022-03-31
- ProPhase Labs, Inc. amortization for the quarter ending 2021-12-31 was -$695.00K.
- ProPhase Labs, Inc. amortization for the quarter ending 2021-09-30 was $924.00K.
- ProPhase Labs, Inc. amortization for the quarter ending 2021-06-30 was $109.00K.
- ProPhase Labs, Inc. amortization for the quarter ending 2021-03-31 was $98.00K.
- ProPhase Labs, Inc. amortization for fiscal 2021 was $436.00K, a 497.26% increase from fiscal 2020.
- ProPhase Labs, Inc. amortization for fiscal 2020 was $73.00K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $229.00K derived: sum of 2 quarters · filed 2022-03-31 | $338.00K derived: sum of 3 quarters · filed 2022-03-31 | $436.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $924.00K 10-Q · filed 2021-11-12 | $1.03M derived: sum of 2 quarters · filed 2021-11-12 | $1.13M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $109.00K 10-Q · filed 2021-08-13 | $207.00K 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | $98.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-31 | |||
| 2020-12-31 | $73.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |